

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.06964036 |
| 2 | DNA deamination (GO:0045006) | 6.01245831 |
| 3 | viral transcription (GO:0019083) | 5.31021776 |
| 4 | translational termination (GO:0006415) | 5.14679926 |
| 5 | translational elongation (GO:0006414) | 4.62146742 |
| 6 | nuclear pore complex assembly (GO:0051292) | 4.60801890 |
| 7 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.41182314 |
| 8 | ribosomal small subunit biogenesis (GO:0042274) | 4.40086598 |
| 9 | protein targeting to ER (GO:0045047) | 4.28397216 |
| 10 | cotranslational protein targeting to membrane (GO:0006613) | 4.27130615 |
| 11 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.25738152 |
| 12 | translational initiation (GO:0006413) | 4.22739005 |
| 13 | maturation of SSU-rRNA (GO:0030490) | 4.19451787 |
| 14 | formation of translation preinitiation complex (GO:0001731) | 4.10636952 |
| 15 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.07343162 |
| 16 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.02657005 |
| 17 | protein localization to endoplasmic reticulum (GO:0070972) | 4.01301111 |
| 18 | viral life cycle (GO:0019058) | 4.00613557 |
| 19 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.96233016 |
| 20 | nuclear pore organization (GO:0006999) | 3.94825172 |
| 21 | mitotic chromosome condensation (GO:0007076) | 3.89808573 |
| 22 | cellular protein complex disassembly (GO:0043624) | 3.89075449 |
| 23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.83496451 |
| 24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.83496451 |
| 25 | folic acid metabolic process (GO:0046655) | 3.83287360 |
| 26 | DNA strand elongation (GO:0022616) | 3.78891303 |
| 27 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.75815914 |
| 28 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.59605850 |
| 29 | negative regulation of RNA splicing (GO:0033119) | 3.58555838 |
| 30 | ribosome assembly (GO:0042255) | 3.57430174 |
| 31 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.55639182 |
| 32 | DNA unwinding involved in DNA replication (GO:0006268) | 3.55293345 |
| 33 | protein complex disassembly (GO:0043241) | 3.52574157 |
| 34 | pore complex assembly (GO:0046931) | 3.51635053 |
| 35 | rRNA transcription (GO:0009303) | 3.49105644 |
| 36 | ribosomal large subunit biogenesis (GO:0042273) | 3.45384408 |
| 37 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.44476443 |
| 38 | telomere maintenance via recombination (GO:0000722) | 3.37118631 |
| 39 | regulation of translational termination (GO:0006449) | 3.36282817 |
| 40 | pseudouridine synthesis (GO:0001522) | 3.35910543 |
| 41 | ribosome biogenesis (GO:0042254) | 3.35129600 |
| 42 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 3.32055924 |
| 43 | mRNA catabolic process (GO:0006402) | 3.29139165 |
| 44 | macromolecular complex disassembly (GO:0032984) | 3.25244979 |
| 45 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.24495667 |
| 46 | mitotic sister chromatid segregation (GO:0000070) | 3.24380986 |
| 47 | rRNA processing (GO:0006364) | 3.22003455 |
| 48 | DNA replication initiation (GO:0006270) | 3.20097934 |
| 49 | RNA catabolic process (GO:0006401) | 3.18751012 |
| 50 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.17611063 |
| 51 | IMP biosynthetic process (GO:0006188) | 3.15525889 |
| 52 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.14900456 |
| 53 | rRNA metabolic process (GO:0016072) | 3.09923705 |
| 54 | definitive hemopoiesis (GO:0060216) | 3.07151046 |
| 55 | nucleobase biosynthetic process (GO:0046112) | 3.06942551 |
| 56 | regulation of RNA export from nucleus (GO:0046831) | 3.06283521 |
| 57 | cellular protein complex localization (GO:0034629) | 3.06000846 |
| 58 | dosage compensation (GO:0007549) | 3.05248229 |
| 59 | mitotic recombination (GO:0006312) | 3.02835419 |
| 60 | sister chromatid segregation (GO:0000819) | 3.02777023 |
| 61 | telomere maintenance via telomere lengthening (GO:0010833) | 3.01820522 |
| 62 | negative regulation of mRNA processing (GO:0050686) | 3.00512571 |
| 63 | IMP metabolic process (GO:0046040) | 2.99892725 |
| 64 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.97026008 |
| 65 | snRNA metabolic process (GO:0016073) | 2.96684538 |
| 66 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.96534478 |
| 67 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.92487626 |
| 68 | DNA conformation change (GO:0071103) | 2.90707745 |
| 69 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.90206062 |
| 70 | proline biosynthetic process (GO:0006561) | 2.89526234 |
| 71 | regulation of histone H3-K4 methylation (GO:0051569) | 2.88742344 |
| 72 | regulation of histone H3-K27 methylation (GO:0061085) | 2.88303941 |
| 73 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.88224115 |
| 74 | mitotic nuclear envelope disassembly (GO:0007077) | 2.87045257 |
| 75 | protein-DNA complex disassembly (GO:0032986) | 2.85351032 |
| 76 | nucleosome disassembly (GO:0006337) | 2.85351032 |
| 77 | protein localization to chromosome, centromeric region (GO:0071459) | 2.83468325 |
| 78 | corticosteroid receptor signaling pathway (GO:0031958) | 2.83251057 |
| 79 | translation (GO:0006412) | 2.83151997 |
| 80 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.81966121 |
| 81 | viral mRNA export from host cell nucleus (GO:0046784) | 2.80657530 |
| 82 | termination of RNA polymerase II transcription (GO:0006369) | 2.80037465 |
| 83 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.79628969 |
| 84 | protein targeting to membrane (GO:0006612) | 2.77587533 |
| 85 | positive regulation of B cell differentiation (GO:0045579) | 2.77300406 |
| 86 | nuclear envelope organization (GO:0006998) | 2.76668261 |
| 87 | protein export from nucleus (GO:0006611) | 2.74831818 |
| 88 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.74790468 |
| 89 | protein complex localization (GO:0031503) | 2.74594145 |
| 90 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.73899560 |
| 91 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.72566460 |
| 92 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.70989066 |
| 93 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.69330821 |
| 94 | T cell apoptotic process (GO:0070231) | 2.68589162 |
| 95 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.68398832 |
| 96 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.68226182 |
| 97 | mRNA export from nucleus (GO:0006406) | 2.67239061 |
| 98 | mitotic nuclear envelope reassembly (GO:0007084) | 2.67077357 |
| 99 | nuclear envelope reassembly (GO:0031468) | 2.67077357 |
| 100 | positive regulation of osteoblast proliferation (GO:0033690) | 2.66297705 |
| 101 | transcription from mitochondrial promoter (GO:0006390) | 2.66266736 |
| 102 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.65801184 |
| 103 | negative regulation of mRNA metabolic process (GO:1903312) | 2.65155241 |
| 104 | mitochondrial DNA metabolic process (GO:0032042) | 2.64837357 |
| 105 | maturation of 5.8S rRNA (GO:0000460) | 2.64766924 |
| 106 | replication fork processing (GO:0031297) | 2.64309216 |
| 107 | folic acid-containing compound metabolic process (GO:0006760) | 2.64238312 |
| 108 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.63678457 |
| 109 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.63523812 |
| 110 | tRNA aminoacylation for protein translation (GO:0006418) | 2.62838875 |
| 111 | membrane disassembly (GO:0030397) | 2.61827541 |
| 112 | nuclear envelope disassembly (GO:0051081) | 2.61827541 |
| 113 | base-excision repair (GO:0006284) | 2.61136431 |
| 114 | regulation of DNA damage checkpoint (GO:2000001) | 2.59642920 |
| 115 | RNA export from nucleus (GO:0006405) | 2.59087533 |
| 116 | regulation of mitochondrial translation (GO:0070129) | 2.58866933 |
| 117 | pentose-phosphate shunt (GO:0006098) | 2.57036608 |
| 118 | protein localization to kinetochore (GO:0034501) | 2.56729540 |
| 119 | snRNA processing (GO:0016180) | 2.56509814 |
| 120 | negative regulation of phagocytosis (GO:0050765) | 2.55270829 |
| 121 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.54800567 |
| 122 | DNA topological change (GO:0006265) | 2.54554859 |
| 123 | amino acid activation (GO:0043038) | 2.54061311 |
| 124 | tRNA aminoacylation (GO:0043039) | 2.54061311 |
| 125 | regulation of translational fidelity (GO:0006450) | 2.53957263 |
| 126 | NIK/NF-kappaB signaling (GO:0038061) | 2.52715597 |
| 127 | peptidyl-arginine methylation (GO:0018216) | 2.52267259 |
| 128 | peptidyl-arginine N-methylation (GO:0035246) | 2.52267259 |
| 129 | COPI coating of Golgi vesicle (GO:0048205) | 2.52242520 |
| 130 | Golgi transport vesicle coating (GO:0048200) | 2.52242520 |
| 131 | RNA methylation (GO:0001510) | 2.52144130 |
| 132 | mRNA cleavage (GO:0006379) | 2.51227147 |
| 133 | DNA duplex unwinding (GO:0032508) | 2.50432326 |
| 134 | lymphocyte apoptotic process (GO:0070227) | 2.49330125 |
| 135 | embryonic process involved in female pregnancy (GO:0060136) | 2.48940311 |
| 136 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.48935048 |
| 137 | purine nucleobase biosynthetic process (GO:0009113) | 2.48884229 |
| 138 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.47527849 |
| 139 | mRNA splicing, via spliceosome (GO:0000398) | 2.47527849 |
| 140 | cellular component biogenesis (GO:0044085) | 2.47374450 |
| 141 | tRNA methylation (GO:0030488) | 2.47056900 |
| 142 | regulation of protein heterodimerization activity (GO:0043497) | 2.47017902 |
| 143 | DNA geometric change (GO:0032392) | 2.45919475 |
| 144 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.45683502 |
| 145 | RNA splicing, via transesterification reactions (GO:0000375) | 2.45338667 |
| 146 | mitochondrial RNA metabolic process (GO:0000959) | 2.41365120 |
| 147 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.41285877 |
| 148 | spliceosomal snRNP assembly (GO:0000387) | 2.40643265 |
| 149 | regulation of gamma-delta T cell activation (GO:0046643) | 2.40478729 |
| 150 | T cell homeostasis (GO:0043029) | 2.40226658 |
| 151 | negative regulation of B cell apoptotic process (GO:0002903) | 2.35685120 |
| 152 | telomere maintenance (GO:0000723) | 2.35342150 |
| 153 | ncRNA processing (GO:0034470) | 2.34897031 |
| 154 | response to protozoan (GO:0001562) | 2.34708354 |
| 155 | telomere organization (GO:0032200) | 2.34319298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.66147954 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.89317122 |
| 3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.80681284 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 3.01863304 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.98980572 |
| 6 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.56770641 |
| 7 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.45997285 |
| 8 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.44176511 |
| 9 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.42595434 |
| 10 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.38545117 |
| 11 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30346782 |
| 12 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.29806506 |
| 13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.19924663 |
| 14 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.10927297 |
| 15 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.10200401 |
| 16 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.08657416 |
| 17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.08579166 |
| 18 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.04906967 |
| 19 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.03185725 |
| 20 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.03039452 |
| 21 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.02324725 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.01013425 |
| 23 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.98721301 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.95350521 |
| 25 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.93980155 |
| 26 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.89691428 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.87911124 |
| 28 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.84031764 |
| 29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.82956042 |
| 30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.81344425 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80304498 |
| 32 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.79461478 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.76728401 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75875482 |
| 35 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.74577988 |
| 36 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.73403547 |
| 37 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69958887 |
| 38 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.65740981 |
| 39 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.62600838 |
| 40 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.60852126 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.60250522 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.59897972 |
| 43 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.59320240 |
| 44 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.59179777 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.58669609 |
| 46 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.57925650 |
| 47 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.57079326 |
| 48 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.56251661 |
| 49 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.55698187 |
| 50 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.55071632 |
| 51 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.54130475 |
| 52 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.53450603 |
| 53 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.51085612 |
| 54 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.49696227 |
| 55 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.49239999 |
| 56 | MYB_26560356_Chip-Seq_TH2_Human | 1.48157018 |
| 57 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.45970039 |
| 58 | UTX_26944678_Chip-Seq_JUKART_Human | 1.45730834 |
| 59 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.45620884 |
| 60 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.44354782 |
| 61 | * MYB_26560356_Chip-Seq_TH1_Human | 1.40928921 |
| 62 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.40022995 |
| 63 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.39707576 |
| 64 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.38142589 |
| 65 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.37276857 |
| 66 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.37180592 |
| 67 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.36119171 |
| 68 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.35632830 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32937984 |
| 70 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.32086137 |
| 71 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.29470525 |
| 72 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.29328440 |
| 73 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.29235673 |
| 74 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.27685519 |
| 75 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.27426492 |
| 76 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.26924174 |
| 77 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.25708294 |
| 78 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24585849 |
| 79 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.24152715 |
| 80 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.23958954 |
| 81 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22835262 |
| 82 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.22420086 |
| 83 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.21655908 |
| 84 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.20430920 |
| 85 | MAF_26560356_Chip-Seq_TH2_Human | 1.18976287 |
| 86 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18896283 |
| 87 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.18419897 |
| 88 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18300468 |
| 89 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.17320987 |
| 90 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.15539645 |
| 91 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.13293308 |
| 92 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13030911 |
| 93 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.12654852 |
| 94 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.11463909 |
| 95 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.11165196 |
| 96 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.09797531 |
| 97 | * AR_21909140_ChIP-Seq_LNCAP_Human | 1.09682934 |
| 98 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.09581659 |
| 99 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08741533 |
| 100 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.06664310 |
| 101 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.06266933 |
| 102 | ATF3_27146783_Chip-Seq_COLON_Human | 1.05936781 |
| 103 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05624024 |
| 104 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04907716 |
| 105 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.04802633 |
| 106 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04182695 |
| 107 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04001959 |
| 108 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.03645342 |
| 109 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03384137 |
| 110 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02595029 |
| 111 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02190659 |
| 112 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.01664726 |
| 113 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.01437943 |
| 114 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.00828376 |
| 115 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00736661 |
| 116 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00395718 |
| 117 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.99940533 |
| 118 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.99757721 |
| 119 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99645140 |
| 120 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99266478 |
| 121 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.98513738 |
| 122 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.97843312 |
| 123 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.97714734 |
| 124 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.96606278 |
| 125 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.96406331 |
| 126 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.96325316 |
| 127 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.95492645 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0002396_abnormal_hematopoietic_system | 3.57823276 |
| 2 | MP0008057_abnormal_DNA_replication | 3.56228894 |
| 3 | MP0003693_abnormal_embryo_hatching | 3.07247419 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.02518628 |
| 5 | MP0005451_abnormal_body_composition | 2.93571368 |
| 6 | MP0005397_hematopoietic_system_phenotyp | 2.80856861 |
| 7 | MP0001545_abnormal_hematopoietic_system | 2.80856861 |
| 8 | MP0004808_abnormal_hematopoietic_stem | 2.63112961 |
| 9 | MP0000685_abnormal_immune_system | 2.59571851 |
| 10 | MP0004957_abnormal_blastocyst_morpholog | 2.50174159 |
| 11 | * MP0010094_abnormal_chromosome_stability | 2.41478758 |
| 12 | MP0002166_altered_tumor_susceptibility | 2.34971762 |
| 13 | MP0000490_abnormal_crypts_of | 2.31103118 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 2.29462967 |
| 15 | MP0003111_abnormal_nucleus_morphology | 2.29179963 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.28331797 |
| 17 | MP0003077_abnormal_cell_cycle | 2.27657156 |
| 18 | MP0010352_gastrointestinal_tract_polyps | 2.25937757 |
| 19 | * MP0002398_abnormal_bone_marrow | 2.21488791 |
| 20 | MP0004233_abnormal_muscle_weight | 2.11386963 |
| 21 | MP0009278_abnormal_bone_marrow | 2.11106671 |
| 22 | MP0003436_decreased_susceptibility_to | 2.06805197 |
| 23 | MP0008007_abnormal_cellular_replicative | 2.00555244 |
| 24 | MP0005671_abnormal_response_to | 1.96403583 |
| 25 | MP0002405_respiratory_system_inflammati | 1.95875543 |
| 26 | MP0001853_heart_inflammation | 1.95127405 |
| 27 | MP0001800_abnormal_humoral_immune | 1.94207799 |
| 28 | MP0000537_abnormal_urethra_morphology | 1.91240432 |
| 29 | * MP0000689_abnormal_spleen_morphology | 1.90276032 |
| 30 | MP0005083_abnormal_biliary_tract | 1.89152027 |
| 31 | MP0008058_abnormal_DNA_repair | 1.87431307 |
| 32 | * MP0002722_abnormal_immune_system | 1.86805683 |
| 33 | MP0000465_gastrointestinal_hemorrhage | 1.86556151 |
| 34 | MP0000703_abnormal_thymus_morphology | 1.85283769 |
| 35 | MP0002006_tumorigenesis | 1.84822413 |
| 36 | MP0001873_stomach_inflammation | 1.84755624 |
| 37 | MP0003315_abnormal_perineum_morphology | 1.82970984 |
| 38 | MP0005174_abnormal_tail_pigmentation | 1.80939801 |
| 39 | MP0004185_abnormal_adipocyte_glucose | 1.73573301 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.71096278 |
| 41 | * MP0002420_abnormal_adaptive_immunity | 1.70871231 |
| 42 | * MP0000716_abnormal_immune_system | 1.69955729 |
| 43 | MP0010307_abnormal_tumor_latency | 1.68721213 |
| 44 | * MP0001819_abnormal_immune_cell | 1.67071489 |
| 45 | MP0009785_altered_susceptibility_to | 1.66325489 |
| 46 | * MP0002452_abnormal_antigen_presenting | 1.66300227 |
| 47 | MP0002723_abnormal_immune_serum | 1.65278653 |
| 48 | * MP0002429_abnormal_blood_cell | 1.64061679 |
| 49 | MP0005075_abnormal_melanosome_morpholog | 1.60633451 |
| 50 | MP0005025_abnormal_response_to | 1.60309105 |
| 51 | MP0005000_abnormal_immune_tolerance | 1.60092446 |
| 52 | MP0003866_abnormal_defecation | 1.59308142 |
| 53 | * MP0002019_abnormal_tumor_incidence | 1.58684801 |
| 54 | MP0006054_spinal_hemorrhage | 1.57950805 |
| 55 | MP0005464_abnormal_platelet_physiology | 1.55698598 |
| 56 | MP0003303_peritoneal_inflammation | 1.54541243 |
| 57 | MP0003786_premature_aging | 1.53892482 |
| 58 | MP0002796_impaired_skin_barrier | 1.50243807 |
| 59 | MP0005501_abnormal_skin_physiology | 1.49033676 |
| 60 | MP0003724_increased_susceptibility_to | 1.41142991 |
| 61 | MP0005387_immune_system_phenotype | 1.38396381 |
| 62 | MP0001790_abnormal_immune_system | 1.38396381 |
| 63 | MP0003300_gastrointestinal_ulcer | 1.34092314 |
| 64 | * MP0000350_abnormal_cell_proliferation | 1.30548026 |
| 65 | MP0003705_abnormal_hypodermis_morpholog | 1.30061429 |
| 66 | MP0000858_altered_metastatic_potential | 1.29943438 |
| 67 | MP0002419_abnormal_innate_immunity | 1.26552219 |
| 68 | MP0000579_abnormal_nail_morphology | 1.22554211 |
| 69 | MP0005621_abnormal_cell_physiology | 1.22212250 |
| 70 | MP0002009_preneoplasia | 1.19545919 |
| 71 | MP0008932_abnormal_embryonic_tissue | 1.16795096 |
| 72 | MP0000313_abnormal_cell_death | 1.16699179 |
| 73 | MP0002148_abnormal_hypersensitivity_rea | 1.16190977 |
| 74 | MP0010234_abnormal_vibrissa_follicle | 1.16028921 |
| 75 | MP0006035_abnormal_mitochondrial_morpho | 1.14028358 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 1.10608793 |
| 77 | MP0005023_abnormal_wound_healing | 1.08593317 |
| 78 | MP0001845_abnormal_inflammatory_respons | 1.08271703 |
| 79 | MP0001730_embryonic_growth_arrest | 1.06009729 |
| 80 | MP0000678_abnormal_parathyroid_gland | 1.05148790 |
| 81 | MP0003453_abnormal_keratinocyte_physiol | 1.04911516 |
| 82 | MP0002132_abnormal_respiratory_system | 1.04646230 |
| 83 | MP0005384_cellular_phenotype | 1.02990343 |
| 84 | MP0009840_abnormal_foam_cell | 1.02038269 |
| 85 | MP0003718_maternal_effect | 1.01470291 |
| 86 | MP0005076_abnormal_cell_differentiation | 1.00419644 |
| 87 | MP0002933_joint_inflammation | 1.00315375 |
| 88 | MP0006036_abnormal_mitochondrial_physio | 0.98807198 |
| 89 | MP0003806_abnormal_nucleotide_metabolis | 0.98073371 |
| 90 | MP0002095_abnormal_skin_pigmentation | 0.97623979 |
| 91 | MP0000358_abnormal_cell_content/ | 0.94862573 |
| 92 | MP0001216_abnormal_epidermal_layer | 0.94275006 |
| 93 | MP0001849_ear_inflammation | 0.94239586 |
| 94 | * MP0002080_prenatal_lethality | 0.93771049 |
| 95 | MP0004947_skin_inflammation | 0.93501059 |
| 96 | MP0001697_abnormal_embryo_size | 0.92118721 |
| 97 | MP0008961_abnormal_basal_metabolism | 0.91342284 |
| 98 | MP0001661_extended_life_span | 0.90815393 |
| 99 | * MP0002086_abnormal_extraembryonic_tissu | 0.90235902 |
| 100 | MP0005666_abnormal_adipose_tissue | 0.90152444 |
| 101 | MP0002877_abnormal_melanocyte_morpholog | 0.89975209 |
| 102 | MP0003567_abnormal_fetal_cardiomyocyte | 0.86792480 |
| 103 | MP0001533_abnormal_skeleton_physiology | 0.86118790 |
| 104 | MP0009379_abnormal_foot_pigmentation | 0.85334815 |
| 105 | MP0000015_abnormal_ear_pigmentation | 0.85207060 |
| 106 | MP0000477_abnormal_intestine_morphology | 0.85010406 |
| 107 | MP0000003_abnormal_adipose_tissue | 0.82564218 |
| 108 | MP0008260_abnormal_autophagy | 0.82432260 |
| 109 | MP0003448_altered_tumor_morphology | 0.81848684 |
| 110 | MP0004197_abnormal_fetal_growth/weight/ | 0.81028197 |
| 111 | MP0005380_embryogenesis_phenotype | 0.80502534 |
| 112 | MP0001672_abnormal_embryogenesis/_devel | 0.80502534 |
| 113 | MP0000627_abnormal_mammary_gland | 0.77843823 |
| 114 | * MP0003984_embryonic_growth_retardation | 0.77065459 |
| 115 | MP0003959_abnormal_lean_body | 0.75759094 |
| 116 | MP0003943_abnormal_hepatobiliary_system | 0.75658315 |
| 117 | MP0003566_abnormal_cell_adhesion | 0.75458673 |
| 118 | MP0004381_abnormal_hair_follicle | 0.74881567 |
| 119 | * MP0002088_abnormal_embryonic_growth/wei | 0.74136586 |
| 120 | MP0005375_adipose_tissue_phenotype | 0.73296391 |
| 121 | * MP0002970_abnormal_white_adipose | 0.73287034 |
| 122 | MP0001348_abnormal_lacrimal_gland | 0.72463839 |
| 123 | MP0008995_early_reproductive_senescence | 0.71901922 |
| 124 | MP0000609_abnormal_liver_physiology | 0.70229157 |
| 125 | * MP0000598_abnormal_liver_morphology | 0.67824906 |
| 126 | MP0009672_abnormal_birth_weight | 0.67596756 |
| 127 | MP0001881_abnormal_mammary_gland | 0.67535260 |
| 128 | MP0004782_abnormal_surfactant_physiolog | 0.67297909 |
| 129 | * MP0005220_abnormal_exocrine_pancreas | 0.67280857 |
| 130 | MP0004858_abnormal_nervous_system | 0.65765092 |
| 131 | MP0009931_abnormal_skin_appearance | 0.65703899 |
| 132 | MP0001915_intracranial_hemorrhage | 0.64919851 |
| 133 | MP0008469_abnormal_protein_level | 0.64375328 |
| 134 | MP0000371_diluted_coat_color | 0.64225184 |
| 135 | * MP0002084_abnormal_developmental_patter | 0.64092644 |
| 136 | MP0009697_abnormal_copulation | 0.63443672 |
| 137 | MP0004147_increased_porphyrin_level | 0.63345029 |
| 138 | MP0002060_abnormal_skin_morphology | 0.63315339 |
| 139 | MP0001663_abnormal_digestive_system | 0.63172648 |
| 140 | MP0004264_abnormal_extraembryonic_tissu | 0.61894185 |
| 141 | MP0005390_skeleton_phenotype | 0.60103714 |
| 142 | MP0002085_abnormal_embryonic_tissue | 0.58758010 |
| 143 | MP0002075_abnormal_coat/hair_pigmentati | 0.56344836 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal number of erythroid precursors (HP:0012131) | 6.06573148 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.99071767 |
| 3 | Microvesicular hepatic steatosis (HP:0001414) | 5.22274308 |
| 4 | Thrombocytosis (HP:0001894) | 4.93728369 |
| 5 | Reticulocytopenia (HP:0001896) | 4.39259004 |
| 6 | Aplastic anemia (HP:0001915) | 4.20999106 |
| 7 | IgM deficiency (HP:0002850) | 3.84491131 |
| 8 | Testicular atrophy (HP:0000029) | 3.83107081 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.76990033 |
| 10 | Ragged-red muscle fibers (HP:0003200) | 3.65322795 |
| 11 | Poikiloderma (HP:0001029) | 3.41566674 |
| 12 | Chronic otitis media (HP:0000389) | 3.41564888 |
| 13 | Pallor (HP:0000980) | 3.36525584 |
| 14 | Petechiae (HP:0000967) | 3.29233466 |
| 15 | Pustule (HP:0200039) | 3.18325927 |
| 16 | Reticulocytosis (HP:0001923) | 3.16703860 |
| 17 | Abnormality of T cell physiology (HP:0011840) | 3.09785182 |
| 18 | Premature ovarian failure (HP:0008209) | 3.00017838 |
| 19 | Progressive external ophthalmoplegia (HP:0000590) | 2.98152984 |
| 20 | Macrocytic anemia (HP:0001972) | 2.94258635 |
| 21 | Septate vagina (HP:0001153) | 2.93084629 |
| 22 | Urethral obstruction (HP:0000796) | 2.91853198 |
| 23 | Hyperacusis (HP:0010780) | 2.86369550 |
| 24 | Prolonged bleeding time (HP:0003010) | 2.82392352 |
| 25 | Panhypogammaglobulinemia (HP:0003139) | 2.80040639 |
| 26 | Recurrent bronchitis (HP:0002837) | 2.77497951 |
| 27 | Abnormality of T cells (HP:0002843) | 2.75793117 |
| 28 | Basal cell carcinoma (HP:0002671) | 2.74596428 |
| 29 | Muscle fiber atrophy (HP:0100295) | 2.73099025 |
| 30 | Recurrent viral infections (HP:0004429) | 2.70612333 |
| 31 | Recurrent fungal infections (HP:0002841) | 2.68909692 |
| 32 | Acute myeloid leukemia (HP:0004808) | 2.65706175 |
| 33 | Sparse lateral eyebrow (HP:0005338) | 2.62739087 |
| 34 | Nasal polyposis (HP:0100582) | 2.60969913 |
| 35 | IgG deficiency (HP:0004315) | 2.59882195 |
| 36 | IgA deficiency (HP:0002720) | 2.58642874 |
| 37 | Myelodysplasia (HP:0002863) | 2.57054300 |
| 38 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.55822240 |
| 39 | Acute lymphatic leukemia (HP:0006721) | 2.55531429 |
| 40 | Reduced antithrombin III activity (HP:0001976) | 2.55227329 |
| 41 | Oral leukoplakia (HP:0002745) | 2.55066240 |
| 42 | Trismus (HP:0000211) | 2.53499579 |
| 43 | Impaired proprioception (HP:0010831) | 2.50468202 |
| 44 | 11 pairs of ribs (HP:0000878) | 2.50178809 |
| 45 | Squamous cell carcinoma (HP:0002860) | 2.49957685 |
| 46 | Broad face (HP:0000283) | 2.49767852 |
| 47 | Abnormality of glycolysis (HP:0004366) | 2.45506026 |
| 48 | * Lymphoma (HP:0002665) | 2.45094534 |
| 49 | Chromsome breakage (HP:0040012) | 2.44258447 |
| 50 | Deviation of the thumb (HP:0009603) | 2.43579962 |
| 51 | Selective tooth agenesis (HP:0001592) | 2.42013050 |
| 52 | Multiple enchondromatosis (HP:0005701) | 2.40943903 |
| 53 | Type 2 muscle fiber atrophy (HP:0003554) | 2.37267326 |
| 54 | Entropion (HP:0000621) | 2.36321457 |
| 55 | Premature graying of hair (HP:0002216) | 2.35699397 |
| 56 | Abnormality of the nasal mucosa (HP:0000433) | 2.35010579 |
| 57 | Lip pit (HP:0100267) | 2.34217921 |
| 58 | Colon cancer (HP:0003003) | 2.34032686 |
| 59 | Dysmetric saccades (HP:0000641) | 2.33719739 |
| 60 | Type I transferrin isoform profile (HP:0003642) | 2.33407846 |
| 61 | Abnormal platelet function (HP:0011869) | 2.25228421 |
| 62 | Impaired platelet aggregation (HP:0003540) | 2.25228421 |
| 63 | Onycholysis (HP:0001806) | 2.24328757 |
| 64 | Proximal placement of thumb (HP:0009623) | 2.22997583 |
| 65 | Albinism (HP:0001022) | 2.22872050 |
| 66 | Pulmonary fibrosis (HP:0002206) | 2.21666136 |
| 67 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.21334994 |
| 68 | Myositis (HP:0100614) | 2.20815462 |
| 69 | Epistaxis (HP:0000421) | 2.20803125 |
| 70 | Abnormality of B cell number (HP:0010975) | 2.18806347 |
| 71 | B lymphocytopenia (HP:0010976) | 2.18806347 |
| 72 | Amaurosis fugax (HP:0100576) | 2.18267724 |
| 73 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.17762033 |
| 74 | Increased density of long bones (HP:0006392) | 2.16032643 |
| 75 | Fatigue (HP:0012378) | 2.12077101 |
| 76 | Cellulitis (HP:0100658) | 2.10516546 |
| 77 | Absent thumb (HP:0009777) | 2.10116606 |
| 78 | Ankyloglossia (HP:0010296) | 2.09469864 |
| 79 | Abnormal gallbladder physiology (HP:0012438) | 2.09242589 |
| 80 | Cholecystitis (HP:0001082) | 2.09242589 |
| 81 | Viral hepatitis (HP:0006562) | 2.09183368 |
| 82 | Abnormality of the fingertips (HP:0001211) | 2.08662870 |
| 83 | Gastrointestinal inflammation (HP:0004386) | 2.07716944 |
| 84 | Abnormal platelet volume (HP:0011876) | 2.05780735 |
| 85 | Hypergonadotropic hypogonadism (HP:0000815) | 2.05325590 |
| 86 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.05148609 |
| 87 | Rough bone trabeculation (HP:0100670) | 2.04161571 |
| 88 | Long palpebral fissure (HP:0000637) | 2.03737087 |
| 89 | Increased serum pyruvate (HP:0003542) | 2.03448576 |
| 90 | Insomnia (HP:0100785) | 2.03277959 |
| 91 | Short middle phalanx of the 5th finger (HP:0004220) | 2.02227499 |
| 92 | Birth length less than 3rd percentile (HP:0003561) | 2.01111625 |
| 93 | Sensory axonal neuropathy (HP:0003390) | 2.00804503 |
| 94 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.00005768 |
| 95 | Abnormality of the thoracic spine (HP:0100711) | 1.99173972 |
| 96 | Hypochromic anemia (HP:0001931) | 1.98672506 |
| 97 | Inflammation of the large intestine (HP:0002037) | 1.98041144 |
| 98 | Pancytopenia (HP:0001876) | 1.97301529 |
| 99 | T lymphocytopenia (HP:0005403) | 1.97250964 |
| 100 | Abnormality of reticulocytes (HP:0004312) | 1.95006874 |
| 101 | Agammaglobulinemia (HP:0004432) | 1.94699656 |
| 102 | Tongue fasciculations (HP:0001308) | 1.93603615 |
| 103 | Abnormality of the prostate (HP:0008775) | 1.92958708 |
| 104 | Colitis (HP:0002583) | 1.92928459 |
| 105 | Lymphopenia (HP:0001888) | 1.91882547 |
| 106 | Achilles tendon contracture (HP:0001771) | 1.90495427 |
| 107 | Deep philtrum (HP:0002002) | 1.90056962 |
| 108 | Milia (HP:0001056) | 1.89425980 |
| 109 | Microretrognathia (HP:0000308) | 1.88740133 |
| 110 | Seborrheic dermatitis (HP:0001051) | 1.88489946 |
| 111 | Hypertensive crisis (HP:0100735) | 1.87391972 |
| 112 | Abnormal hair laboratory examination (HP:0003328) | 1.87270940 |
| 113 | Cutaneous melanoma (HP:0012056) | 1.87082882 |
| 114 | Short 5th finger (HP:0009237) | 1.86586926 |
| 115 | Abnormal protein glycosylation (HP:0012346) | 1.86183051 |
| 116 | Abnormal glycosylation (HP:0012345) | 1.86183051 |
| 117 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.86183051 |
| 118 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.86183051 |
| 119 | Severe combined immunodeficiency (HP:0004430) | 1.86109280 |
| 120 | Degeneration of anterior horn cells (HP:0002398) | 1.85227862 |
| 121 | Abnormality of the anterior horn cell (HP:0006802) | 1.85227862 |
| 122 | Ureteral duplication (HP:0000073) | 1.83480451 |
| 123 | Eczematoid dermatitis (HP:0000976) | 1.83323711 |
| 124 | Mediastinal lymphadenopathy (HP:0100721) | 1.82048224 |
| 125 | Abnormality of T cell number (HP:0011839) | 1.81889341 |
| 126 | Nasolacrimal duct obstruction (HP:0000579) | 1.81887489 |
| 127 | Deep palmar crease (HP:0006191) | 1.81822664 |
| 128 | Joint stiffness (HP:0001387) | 1.81380438 |
| 129 | Pili torti (HP:0003777) | 1.79256729 |
| 130 | Long eyelashes (HP:0000527) | 1.79060571 |
| 131 | Hepatitis (HP:0012115) | 1.78954534 |
| 132 | Thoracic kyphosis (HP:0002942) | 1.78822263 |
| 133 | Ridged nail (HP:0001807) | 1.75962201 |
| 134 | Abnormal number of incisors (HP:0011064) | 1.73958179 |
| 135 | Prostate neoplasm (HP:0100787) | 1.73899933 |
| 136 | Self-mutilation (HP:0000742) | 1.72907129 |
| 137 | Increased mean platelet volume (HP:0011877) | 1.72368371 |
| 138 | Overlapping toe (HP:0001845) | 1.72272541 |
| 139 | Natal tooth (HP:0000695) | 1.71923418 |
| 140 | Abnormal trabecular bone morphology (HP:0100671) | 1.71840453 |
| 141 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.71495618 |
| 142 | Facial hemangioma (HP:0000329) | 1.71142293 |
| 143 | Abnormality of the preputium (HP:0100587) | 1.70971174 |
| 144 | Increased serum ferritin (HP:0003281) | 1.70539682 |
| 145 | Exertional dyspnea (HP:0002875) | 1.70428958 |
| 146 | Prominent nose (HP:0000448) | 1.69887527 |
| 147 | Progressive muscle weakness (HP:0003323) | 1.69562143 |
| 148 | Secondary amenorrhea (HP:0000869) | 1.69164276 |
| 149 | Abnormality of the columella (HP:0009929) | 1.69117362 |
| 150 | Meningitis (HP:0001287) | 1.69106752 |
| 151 | Preauricular skin tag (HP:0000384) | 1.69100972 |
| 152 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.68788020 |
| 153 | Micronodular cirrhosis (HP:0001413) | 1.68705356 |
| 154 | Skin ulcer (HP:0200042) | 1.67937113 |
| 155 | Elbow flexion contracture (HP:0002987) | 1.67857630 |
| 156 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.66836193 |
| 157 | Increased IgM level (HP:0003496) | 1.65449778 |
| 158 | Recurrent abscess formation (HP:0002722) | 1.64803122 |
| 159 | Broad palm (HP:0001169) | 1.64785136 |
| 160 | Bone marrow hypocellularity (HP:0005528) | 1.64674560 |
| 161 | Muscle fibrillation (HP:0010546) | 1.64397447 |
| 162 | Microcytic anemia (HP:0001935) | 1.64197382 |
| 163 | Abnormality of oral frenula (HP:0000190) | 1.64041948 |
| 164 | Abnormality of male internal genitalia (HP:0000022) | 1.63730728 |
| 165 | Nail dystrophy (HP:0008404) | 1.63462283 |
| 166 | Abnormality of the Achilles tendon (HP:0005109) | 1.62927105 |
| 167 | Missing ribs (HP:0000921) | 1.60508122 |
| 168 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.59503019 |
| 169 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.59332705 |
| 170 | Villous atrophy (HP:0011473) | 1.59332705 |
| 171 | Abnormal blistering of the skin (HP:0008066) | 1.56923947 |
| 172 | Increased nuchal translucency (HP:0010880) | 1.56869175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EEF2K | 3.95159598 |
| 2 | SMG1 | 3.80149267 |
| 3 | MAP4K1 | 3.74975225 |
| 4 | NME2 | 2.71164749 |
| 5 | FLT3 | 2.38597367 |
| 6 | IRAK3 | 2.34565841 |
| 7 | VRK2 | 2.16399935 |
| 8 | MAP3K11 | 2.13221853 |
| 9 | PRPF4B | 2.09789772 |
| 10 | WEE1 | 2.06259365 |
| 11 | TXK | 2.06145713 |
| 12 | ZAP70 | 2.03496243 |
| 13 | RPS6KB2 | 2.02410369 |
| 14 | PDK2 | 1.89738950 |
| 15 | PKN2 | 1.82735942 |
| 16 | KIT | 1.80816898 |
| 17 | JAK3 | 1.80142033 |
| 18 | BTK | 1.78895374 |
| 19 | TEC | 1.77614613 |
| 20 | CDC7 | 1.75998780 |
| 21 | MAP3K10 | 1.71652688 |
| 22 | TGFBR1 | 1.62740798 |
| 23 | CDK7 | 1.62558402 |
| 24 | STK16 | 1.61541536 |
| 25 | EPHA2 | 1.58782627 |
| 26 | MAP2K3 | 1.57993165 |
| 27 | STK10 | 1.57387666 |
| 28 | RPS6KA4 | 1.55476392 |
| 29 | LRRK2 | 1.54392375 |
| 30 | DYRK3 | 1.53602624 |
| 31 | MST1R | 1.51529004 |
| 32 | EIF2AK1 | 1.46015833 |
| 33 | BUB1 | 1.44026646 |
| 34 | MATK | 1.41411574 |
| 35 | MAPKAPK3 | 1.40637343 |
| 36 | NME1 | 1.39031060 |
| 37 | SIK1 | 1.37707266 |
| 38 | AURKA | 1.37083524 |
| 39 | PBK | 1.36910892 |
| 40 | * MTOR | 1.36732724 |
| 41 | TSSK6 | 1.35136250 |
| 42 | ACVR1B | 1.33208888 |
| 43 | CAMK1D | 1.26098989 |
| 44 | IKBKB | 1.24135671 |
| 45 | MAP3K6 | 1.23834956 |
| 46 | TRIB3 | 1.23000174 |
| 47 | * PIM1 | 1.22145844 |
| 48 | KDR | 1.17786005 |
| 49 | PASK | 1.17738915 |
| 50 | ATR | 1.13993264 |
| 51 | TAOK1 | 1.10045501 |
| 52 | TTK | 1.07986982 |
| 53 | EIF2AK3 | 1.07354305 |
| 54 | BRSK2 | 1.06678521 |
| 55 | MKNK1 | 1.06453075 |
| 56 | TAOK2 | 1.06181782 |
| 57 | SCYL2 | 1.05549801 |
| 58 | VRK1 | 1.05523943 |
| 59 | CDK4 | 1.03334738 |
| 60 | TBK1 | 1.02949291 |
| 61 | NEK1 | 1.02359399 |
| 62 | BCKDK | 1.01582259 |
| 63 | TESK2 | 1.00447338 |
| 64 | ERN1 | 0.99135345 |
| 65 | TRPM7 | 0.99116157 |
| 66 | BRD4 | 0.97909779 |
| 67 | CSF1R | 0.97131950 |
| 68 | ITK | 0.94870850 |
| 69 | CDK8 | 0.94817466 |
| 70 | NEK2 | 0.94529002 |
| 71 | CSK | 0.92480515 |
| 72 | SYK | 0.91961635 |
| 73 | LCK | 0.91356017 |
| 74 | MAP3K3 | 0.91346337 |
| 75 | CHUK | 0.90953336 |
| 76 | TAOK3 | 0.89924453 |
| 77 | CDK6 | 0.89357910 |
| 78 | NLK | 0.86148058 |
| 79 | MAP3K8 | 0.85309938 |
| 80 | ICK | 0.83783703 |
| 81 | TYK2 | 0.83605457 |
| 82 | AURKB | 0.81202494 |
| 83 | RPS6KA6 | 0.80854294 |
| 84 | LYN | 0.80827426 |
| 85 | BLK | 0.80762627 |
| 86 | MAPK15 | 0.78901954 |
| 87 | MKNK2 | 0.76379127 |
| 88 | SRPK1 | 0.75221565 |
| 89 | DAPK1 | 0.75061898 |
| 90 | CCNB1 | 0.74959203 |
| 91 | RPS6KC1 | 0.73747624 |
| 92 | RPS6KL1 | 0.73747624 |
| 93 | TAF1 | 0.70372433 |
| 94 | IKBKE | 0.70040598 |
| 95 | EIF2AK2 | 0.69596428 |
| 96 | GRK6 | 0.69499325 |
| 97 | CAMK1G | 0.65507366 |
| 98 | CDK9 | 0.65233258 |
| 99 | * CDK2 | 0.64959226 |
| 100 | MAP3K13 | 0.64462573 |
| 101 | PAK4 | 0.64114917 |
| 102 | ARAF | 0.63369979 |
| 103 | PLK1 | 0.62047451 |
| 104 | TNK2 | 0.61062430 |
| 105 | HCK | 0.60981704 |
| 106 | IRAK4 | 0.60485235 |
| 107 | MAPKAPK2 | 0.60315641 |
| 108 | LATS2 | 0.59989150 |
| 109 | MAPK11 | 0.59786658 |
| 110 | MAP3K14 | 0.59148043 |
| 111 | MAPK4 | 0.58872202 |
| 112 | CHEK1 | 0.56861737 |
| 113 | ZAK | 0.56104068 |
| 114 | HIPK2 | 0.54458556 |
| 115 | RPS6KA1 | 0.54277453 |
| 116 | CDK12 | 0.54082542 |
| 117 | ATM | 0.53093522 |
| 118 | MAP3K1 | 0.52962983 |
| 119 | MAP2K2 | 0.52880810 |
| 120 | TLK1 | 0.52797027 |
| 121 | BRSK1 | 0.51602641 |
| 122 | DDR2 | 0.50291462 |
| 123 | MAPKAPK5 | 0.50205067 |
| 124 | MELK | 0.49480866 |
| 125 | CLK1 | 0.49460033 |
| 126 | ALK | 0.48647467 |
| 127 | * CDK1 | 0.48426014 |
| 128 | TGFBR2 | 0.47270613 |
| 129 | * CSNK2A2 | 0.46485983 |
| 130 | CDK19 | 0.45997008 |
| 131 | CHEK2 | 0.45287150 |
| 132 | ILK | 0.44591489 |
| 133 | RPS6KA5 | 0.43554204 |
| 134 | RPS6KB1 | 0.43156511 |
| 135 | AKT2 | 0.41059814 |
| 136 | IRAK2 | 0.40279565 |
| 137 | PRKCI | 0.40025137 |
| 138 | FGFR4 | 0.38967437 |
| 139 | NEK6 | 0.36394830 |
| 140 | STK4 | 0.35230883 |
| 141 | MARK2 | 0.32852376 |
| 142 | AKT1 | 0.32541031 |
| 143 | SIK2 | 0.31775190 |
| 144 | MAP3K7 | 0.30039025 |
| 145 | EPHA3 | 0.29868263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.33575343 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.05116254 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.36687932 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 3.08485710 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.87751842 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 2.67319773 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.20247557 |
| 8 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.18292396 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 2.14504862 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.12408524 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 2.05413657 |
| 12 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.96131399 |
| 13 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.87528474 |
| 14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.80935495 |
| 15 | * Cell cycle_Homo sapiens_hsa04110 | 1.74514093 |
| 16 | Proteasome_Homo sapiens_hsa03050 | 1.69391937 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.67262429 |
| 18 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.66212856 |
| 19 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.61698277 |
| 20 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.58259101 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.57445352 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.54936680 |
| 23 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.51423344 |
| 24 | RNA degradation_Homo sapiens_hsa03018 | 1.46313520 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.46283891 |
| 26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.44419811 |
| 27 | Carbon metabolism_Homo sapiens_hsa01200 | 1.43182439 |
| 28 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.40800569 |
| 29 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.40511994 |
| 30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.35222897 |
| 31 | Lysine degradation_Homo sapiens_hsa00310 | 1.27837027 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.24395021 |
| 33 | Leishmaniasis_Homo sapiens_hsa05140 | 1.23653285 |
| 34 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.22582038 |
| 35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.22132545 |
| 36 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.20778658 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.20241256 |
| 38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.19376133 |
| 39 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.18751271 |
| 40 | Sulfur relay system_Homo sapiens_hsa04122 | 1.15881828 |
| 41 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.13473023 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.12119396 |
| 43 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.11696651 |
| 44 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.09748896 |
| 45 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.08743011 |
| 46 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.07830017 |
| 47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.07766225 |
| 48 | * Bladder cancer_Homo sapiens_hsa05219 | 1.06866223 |
| 49 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.06364854 |
| 50 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.99064910 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 0.96910512 |
| 52 | * Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.96613815 |
| 53 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.96372450 |
| 54 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.96020372 |
| 55 | * Hepatitis B_Homo sapiens_hsa05161 | 0.95740615 |
| 56 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.95722249 |
| 57 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.94581089 |
| 58 | Allograft rejection_Homo sapiens_hsa05330 | 0.93291009 |
| 59 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.92690189 |
| 60 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.92454713 |
| 61 | Basal transcription factors_Homo sapiens_hsa03022 | 0.89755290 |
| 62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.89002201 |
| 63 | * Small cell lung cancer_Homo sapiens_hsa05222 | 0.87198360 |
| 64 | Alcoholism_Homo sapiens_hsa05034 | 0.84618829 |
| 65 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.84150245 |
| 66 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.82323224 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79801090 |
| 68 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.79439314 |
| 69 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77186430 |
| 70 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74441544 |
| 71 | Purine metabolism_Homo sapiens_hsa00230 | 0.74353479 |
| 72 | Asthma_Homo sapiens_hsa05310 | 0.73236535 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.70839190 |
| 74 | Influenza A_Homo sapiens_hsa05164 | 0.68301402 |
| 75 | Protein export_Homo sapiens_hsa03060 | 0.68122350 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67899846 |
| 77 | Prostate cancer_Homo sapiens_hsa05215 | 0.66250945 |
| 78 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.64436486 |
| 79 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.64090864 |
| 80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.63442827 |
| 81 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63196570 |
| 82 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.61633967 |
| 83 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59393120 |
| 84 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.58970363 |
| 85 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.58468065 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58441753 |
| 87 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.56864828 |
| 88 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.56828622 |
| 89 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56466772 |
| 90 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56068672 |
| 91 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.55693739 |
| 92 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55612362 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55366887 |
| 94 | * Thyroid cancer_Homo sapiens_hsa05216 | 0.54831226 |
| 95 | Malaria_Homo sapiens_hsa05144 | 0.53909170 |
| 96 | Platelet activation_Homo sapiens_hsa04611 | 0.52950835 |
| 97 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.52623179 |
| 98 | Other glycan degradation_Homo sapiens_hsa00511 | 0.50735716 |
| 99 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.50008264 |
| 100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.49712161 |
| 101 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47569255 |
| 102 | Pertussis_Homo sapiens_hsa05133 | 0.45957661 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45501672 |
| 104 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44798624 |
| 105 | * Colorectal cancer_Homo sapiens_hsa05210 | 0.43774591 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.43048570 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.41627121 |
| 108 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40793550 |
| 109 | Salmonella infection_Homo sapiens_hsa05132 | 0.40109693 |
| 110 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39742718 |
| 111 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.39540394 |
| 112 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.38807854 |
| 113 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38778805 |
| 114 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38673146 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38111827 |
| 116 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.37879426 |
| 117 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.37839788 |
| 118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37505833 |
| 119 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37236419 |
| 120 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37032811 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35809778 |
| 122 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.35482672 |
| 123 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.34382150 |
| 124 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.33597744 |
| 125 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.33339567 |
| 126 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.33176586 |
| 127 | Glioma_Homo sapiens_hsa05214 | 0.32707852 |
| 128 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30696345 |
| 129 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.27683964 |
| 130 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.27026109 |
| 131 | * Endometrial cancer_Homo sapiens_hsa05213 | 0.24491204 |
| 132 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.21768104 |

